Visits: 1881, Avg visit time (secs): 274,66 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 738 | 39,23% | |
| /recipients.html | 172 | 9,14% |
| /sanofi-aventis/endocannabinoid/efsd-sanofi-aventis-ecs-recipients.html | 147 | 7,81% |
| /amylin/efsd-amylin-recipients.html | 143 | 7,60% |
| /lilly/efsd-lilly-recipients.html | 54 | 2,87% |
| /efsd-grant/efsd-clinres-recipients.html | 40 | 2,13% |
| /lifescan/efsd-lifescan-recipients.html | 33 | 1,75% |
| /efsd-jdrf-novo/efsd-jdrf-novo-t1-recipients.html | 32 | 1,70% |
| /pfizer/efsd-pfizer-recipients.html | 30 | 1,59% |
| /novo-clinical-t2/efsd-novo-clin-t2-recipients.html | 24 | 1,28% |
| /msd/efsd-msd-recipients.html | 24 | 1,28% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 914 | 48,59% |
| /sanofi-aventis/endocannabinoid/efsd-sanofi-aventis-ecs-recipients.html | 212 | 11,27% |
| /sanofi-aventis/micro_macro/recipientsmicro_macro.html | 55 | 2,92% |
| /efsd-grant/efsd-clinres-recipients.html | 49 | 2,60% |
| /amylin/efsd-amylin-recipients.html | 38 | 2,02% |
| /novartis/efsd-novartis-recipients.html | 34 | 1,81% |
| /programmes.html | 31 | 1,65% |
| /lilly/efsd-lilly-recipients.html | 31 | 1,65% |
| /bms/efsd-bms-recipients.html | 25 | 1,33% |
| /novo-clinical-t2/efsd-novo-clin-t2-recipients.html | 25 | 1,33% |
| /msd/efsd-msd-recipients-islet.html | 24 | 1,28% |